Branded Legacy, Inc Announces
White Label Deal with Kava & Hobbs, LLC for Kava Vape
formulation
"Branded Legacy Strengthens Relationship with Surge
Distribution Company, bolstering quarter 1 revenue"
Melbourne, FL -- April 4, 2024 --
InvestorsHub NewsWire -- Branded Legacy, Inc,
(OTC.PK: BLEG)
a leading provider of innovative
wellness products, proudly announces a significant white label
agreement between its subsidiary Royal Biotek and Kava & Hobbs,
LLC. This collaboration signifies a milestone in the burgeoning
market for wellness-oriented vaping products.
Under the terms of the
agreement, Branded Legacy will supply Kava & Hobbs with 6,000
units of their groundbreaking
Kava Vapes per order, valued at just under $50,000. These
state-of-the-art vaping products feature a unique formulation
comprising CBD and terpene blends, paired with proprietary
high-purity kava extract, distinguishing them as an unparalleled
offering in the market.
Royal Biotek's expertise in
product development and branding has led to the creation of two
distinct products for Kava & Hobbs: Sleepy Tiki and Zen Tiki.
Crafted to promote relaxation and support restful sleep, these
vapes embody tranquility and balance, offering consumers an
unmatched vaping experience that fosters wellness and
mindfulness.
"We are excited to partner
with Kava & Hobbs, expanding the reach of our innovative Kava
Vapes," said David Oswald, CEO of Branded Legacy, Inc. "This white
label deal reflects our commitment to delivering high-quality,
effective products that cater to the evolving needs of consumers
seeking holistic wellness solutions."
Kava & Hobbs, LLC,
shares Branded Legacy's vision for wellness-centric products that
prioritize natural ingredients and consumer well-being. The
partnership underscores both companies' dedication to excellence
and innovation in the rapidly expanding market for both CBD and
Kava-based products.
Branded Legacy also
announced the signing of two more white label agreements with Surge
Distribution Company. These new deals, with a combined value
totaling approximately $50,000 per order, increases revenue from
quarter one by over $100,000.
"Branded Legacy is experiencing exponential revenue
growth, demonstrating the success of our strategic partnerships and
commitment to innovation," stated Oswald.
Looking ahead to quarter
two, Branded Legacy is already actively negotiating four additional
white label deals and a large extraction contract, positioning the
company for continued success and expansion in the rapidly growing
wellness market.
In Other Company News,
Branded Legacy recently announced the strategic acquisition of
Sycamore BioPharma, Inc., a renowned developer of plant-based
pharmaceuticals. This milestone solidifies Branded Legacy's
position in the biotech sector, securing assets exceeding $2
million and key personnel crucial for advancing clinical trials.
The acquisition not only expands Branded Legacy's portfolio with
over $500,000 in inventory but also fosters synergies to drive
sales growth and consumer outreach. Additionally, the collaboration
welcomes Dr. Mark Hamann, a PHD holding scientist, to Branded
Legacy's team, enhancing efforts in pharmaceutical development and
FDA approval processes.
For
more information about Sycamore BioPharma, Inc, please
visit: https://sycamorebp.com/
Original Copy of this Press Release:
https://brandedlegacy.com/branded-legacy-inc-announces-white-label-deal-with-kava-hobbs-llc-for-kava-vape-formulation/
For
media inquiries, please contact:
Investor Relations & Media Contact
Joe
Holladay
Branded Legacy
Phone:
321-345-3565
Email:
info@brandedlegacy.com
Website: https://brandedlegacy.com/
About
Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified
holdings company focused on the biotech sector. With a commitment
to excellence and innovation, Branded Legacy specializes in the
development and marketing of cutting-edge products and services,
including ventures in biotechnology, digital solutions, and
wellness products.
Safe
Harbor Statement on Forward-Looking Language:
This
release includes forward-looking statements, subject to risks and
uncertainties that could cause actual results to differ materially
from current expectations. The company disclaims any intention or
obligation to update or revise forward-looking statements.
Forward-looking statements may be identified by words such as
"may," "will," "expect," "believe," "anticipate," "estimate," and
similar expressions.
Branded Legacy (PK) (USOTC:BLEG)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Branded Legacy (PK) (USOTC:BLEG)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024